Literature DB >> 1696763

Intestinal differentiation in ovarian mucinous tumours.

N J Ball1, D I Robertson, M A Duggan, D D Snider.   

Abstract

Fifty-five ovarian mucinous tumours, 22 benign, 16 borderline and 17 malignant, were examined for intestinal differentiation (ID). This was defined by the presence of one or more of endocrine, absorptive, goblet or Paneth cells, and identified by routine haematoxylin and eosin as well as histochemical and immunoperoxidase techniques. Twenty benign (91%), 14 borderline (88%) and all malignant tumours contained foci of ID. The frequency of ID was not significantly different between the mucinous tumour types (chi-squared test for independence). Follow-up was available on all patients with borderline tumours: 14 were stage Ia, including both cases without ID, and 2 were stage Ic at presentation. All are alive and free of disease at 9-39 months (median 15.5 months). We conclude that the presence of ID in borderline mucinous tumours is unlikely to be of prognostic significance, and that a subdivision of these tumours into müllerian and intestinal types is unnecessary.

Entities:  

Mesh:

Year:  1990        PMID: 1696763     DOI: 10.1007/bf01600134

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  33 in total

1.  ARGYROPHIL AND ARGENTAFFIN CELLS IN THE FEMALE GENITAL TRACT AND IN OVARIAN MUCINOUS CYSTS.

Authors:  H FOX; B KAZZAZ; F A LANGLEY
Journal:  J Pathol Bacteriol       Date:  1964-10

2.  High iron diamine-alcian blue mucin profiles in benign, premalignant and malignant colorectal disease.

Authors:  D C Allen; N S Connolly; J D Biggart
Journal:  Histopathology       Date:  1988-10       Impact factor: 5.087

3.  Ultrastructure and immunohistochemistry of gastro-entero-pancreatic (GEP) endocrine cells in mucinous tumors of the ovary.

Authors:  A Takeda; M Matsuyama; T Chihara; T Suchi; T Sato; Y Tomoda
Journal:  Acta Pathol Jpn       Date:  1982-11

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Endometrial carcinoma with argyrophil cells: a histochemical and immunohistochemical analysis.

Authors:  P Aguirre; R E Scully; H J Wolfe; R A DeLellis
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

6.  Malignant transformation of mucinous ovarian cystadenomas of intestinal epithelial type.

Authors:  K Szymańska; J Szamborski; N Miechowiecka; W Czerwiński
Journal:  Histopathology       Date:  1983-07       Impact factor: 5.087

7.  Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.

Authors:  M L Friedlander; P Russell; I W Taylor; D W Hedley; M H Tattersall
Journal:  Pathology       Date:  1984-07       Impact factor: 5.306

8.  Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material.

Authors:  S Silva; M I Filipe
Journal:  Hum Pathol       Date:  1986-10       Impact factor: 3.466

9.  Immunohistological study of mucous antigens in gynecologic tumors with special reference to argyrophil cells.

Authors:  G Ueda; Y Tanaka; K Hiramatsu; Y Inoue; M Yamasaki; M Inoue; K Kurachi; T Mori
Journal:  Int J Gynecol Pathol       Date:  1982       Impact factor: 2.762

10.  Mucinous tumors of the ovary with argyrophil cells. An immunohistochemical analysis.

Authors:  P Aguirre; R E Scully; Y Dayal; R A DeLellis
Journal:  Am J Surg Pathol       Date:  1984-05       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.